CrossRef Text and Data Mining
Result of CrossRef Text and Data Mining Search is the related articles with entitled article. If you click link1 or link2 you will be able to reach the full text site of selected articles; however, some links do not show the full text immediately at now. If you click CrossRef Text and Data Mining Download icon, you will be able to get whole list of articles from literature included in CrossRef Text and Data Mining.
Prevalence and Prognostic Role of PIK3CA/AKT1 Mutations in Chinese Breast Cancer Patients
Ling Deng, Xuehua Zhu, Yun Sun, Jiemin Wang, Xiaorong Zhong, Jiayuan Li, Min Hu, Hong Zheng
Cancer Research and Treatment. 2019;51(1):128-140.   Published online 2018 March 15    DOI: https://doi.org/10.4143/crt.2017.598

Excel Download

Prevalence and Prognostic Role of PIK3CA/AKT1 Mutations in Chinese Breast Cancer Patients
Cancer Research and Treatment. 2019;51(1):128-140   Crossref logo
Link1 Link2 Link3

Activation of the PI3K/AKT signalling pathway in non-melanoma skin cancer is not mediated by oncogenic PIK3CA and AKT1 hotspot mutations
Experimental Dermatology. 2010;19(8):e222-e227   Crossref logo
Link1

Prevalence and spectrum of AKT1, PIK3CA, PTEN and TP53 somatic mutations in Chinese breast cancer patients
PLOS ONE. 2018;13(9):e0203495   Crossref logo
Link1

Defining the Prognostic and Predictive Role of PIK3CA Mutations: Sifting Through the Conflicting Data
Current Breast Cancer Reports. 2016;8(2):73-79   Crossref logo
Link1 Link2 Link3

PIK3CA mutations define favorable prognostic biomarkers in operable breast cancer: a systematic review and meta-analysis
OncoTargets and Therapy. 2014;543   Crossref logo
Link1

299PThe prevalence of PIK3CA mutations in HR+/HER2– metastatic breast cancer (BELLE2, BELLE3 and BOLERO2 clinical trials)
Annals of Oncology. 2018;29(suppl_8):   Crossref logo
Link1

PIK3CA mutations in breast cancer: reconciling findings from preclinical and clinical data
Breast Cancer Research. 2014;16(1):   Crossref logo
Link1 Link2 Link3

Prevalence of BRCA1 and BRCA2 Mutations in Male Breast Cancer Patients in Canada
Clinical Breast Cancer. 2000;1(1):57-63   Crossref logo
Link1 Link2

Commentary on “Prevalence of BRCA1 and BRCA2 Mutations in Male Breast Cancer Patients in Canada”
Clinical Breast Cancer. 2000;1(1):64-65   Crossref logo
Link1 Link2

Array CGH and PIK3CA/AKT1 mutations to drive patients to specific targeted agents: A clinical experience in 108 patients with metastatic breast cancer
European Journal of Cancer. 2012;48(15):2293-2299   Crossref logo
Link1 Link2

This metadata service is kindly provided by CrossRef from May 29, 2014. Cancer Res Treat has participated in CrossRef Text and Data Mining service since October 29, 2014.